SURMODICS INC — Director's Dealing 2022

Apr 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2022-04-01

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-04-01	Common Stock	S	3900	$44.9742	Disposed	155141	Direct
2022-04-01	Common Stock	S	100	$45.55	Disposed	155041	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.

F2: Reflects the weighted average price of 3,900 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on April 1, 2022 with sale prices ranging from $44.49 to $45.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes 308 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/22.